Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Comparison of Illumigene, Simplexa, and AmpliVue Clostridium difficile Molecular Assays for Diagnosis of C. difficile Infection

19 Dec 2013

Abstract excerpt

We compared the performance of the Simplexa Universal Direct (Focus Diagnostics) and AmpliVue (Quidel Corporation) assays to that of the Illumigene assay (Meridian Bioscience, Inc.) for the diagnosis of Clostridium difficile infection. Two hundred deidentified remnant diarrheal stool specimens were tested by the Simplexa, AmpliVue, and Illumigene methods. Specimens with discrepant results among the three assays...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Clostridium difficile and Clostridium perfringens research
Share to Microscopic Colitis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 24352999
DOI: 10.1128/jcm.02354-13

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Comparison of Illumigene, Simplexa, and AmpliVue Clostridium difficile Molecular Assays for Diagnosis of C. difficile InfectionPMID 24352999Read ↗

A novel RNA nucleic acid amplification test more accurately distinguishes active <i>Clostridioides difficile</i> infection from colonizationSemantic proximity Read ↗

Comparative Evaluation of Two Commercial Multiplex Panels for Detection of Gastrointestinal Pathogens by Use of Clinical Stool SpecimensSemantic proximity Read ↗

Increased Clinical Specificity with Ultrasensitive Detection of Clostridioides difficile Toxins: Reduction of Overdiagnosis Compared to Nucleic Acid Amplification TestsSemantic proximity Read ↗

Predictors of Clostridioides difficile Infection-Related Complications and Treatment Patterns among Nucleic Acid Amplification Test-Positive/Toxin Enzyme Immunoassay-Negative PatientsSemantic proximity Read ↗

Multiplex PCR for gastrointestinal parasites in stool: Benchmarking against direct microscopy and simplex PCRSemantic proximity Read ↗

Evaluation of the Cepheid Xpert Clostridium difficile Epi assay for diagnosis of Clostridium difficile infection and typing of the NAP1 strain at a cancer hospital.Semantic proximity Read ↗

Clinical utility of the GeneXpert assay for the diagnosis of Clostridium difficile infectionsSemantic proximity Read ↗

Performing Reflexive Toxin A/B Enzyme Immunoassay in a Two-Step Algorithm for the Diagnosis of <i>Clostridium difficile</i> Infection Has Limited Clinical UtilitySemantic proximity Read ↗

Dual probe DNA capture for sensitive real-time PCR detection of Cryptosporidium and GiardiaSemantic proximity Read ↗

Comparison of Real-Time PCR for Detection of the <i>tcdC</i> Gene with Four Toxin Immunoassays and Culture in Diagnosis of <i>Clostridium difficile</i> InfectionSemantic proximity Read ↗

Development and clinical application of a rapid and visual loop-mediated isothermal amplification test for tetM gene in Clostridioides difficile strains cultured from fecesSemantic proximity Read ↗

Automated Detection of Toxigenic Clostridium difficile in Clinical Samples: Isothermal <i>tcdB</i> Amplification Coupled to Array-Based DetectionSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.